Canadian Cancer Trials Group (CCTG) recognizes the value and importance of engaging patients, including the patient voice in all aspects of the clinical trial life-cycle. Integrating the patient perspective into the CCTG’s overall strategic agenda ensures the research agenda has the greatest impact on cancer patients in Canada and around the world.

CCTG has implemented a model of dedicated public and patient involvement by including the Patient Representative, who are patient volunteers recruited to disease site committees similar to academic committee members with a three year extendable term.

• The role of the CCTG Patient Representative has evolved to integrate the patient perspective into many steps of the research process with the aim of:
  • research questions that matter to patients, and
  • improved accrual
• CCTG is committed to implementing best practices and materials to foster and facilitate patient engagement

If you are looking for more information about the CCTG Patient Representative Committee please contact Yvonne Murray, Patient Engagement Lead for information.

CCTG is not currently looking for volunteers at this time. For more information about current committee openings please contact Nancy Dusharm.

Priorities in cancer research

CCTG Patient Representatives participated in a facilitated workshop session to identify six research topics most important to cancer patients and caregivers. For the results >

CCTG Patient Representative Committee

Bob Taylor

Carol Gordon

Bill Richardson

Erwin Wanderer

Janice Hodgson

Joan Petrie

Hilary Horlock

Catherine Wreford

Marie-Térèse Little

Martina Wood

Michelle Audoin  

Emi Bossio

Lindsay Clarke

Sally Nystrom

Louise Bird

Jasmine Heuring

Haydn Bechthold

Suzanne Wood

Carol Hill

Deb Clarke

Ruth Ackerman

Dawn Barker

Melissa Coombs